Company
Nxera Pharma CO., LTD.
Nxera Pharma CO., LTD. is an active UK company (number FC024112), incorporated 2002, with 4 current directors including Eiko Tomita and Christopher Cargill. Source: Companies House, updated 4th October 2026.
Official record Companies House · updated 4th October 2026 · Sources
Network
The large node is Nxera Pharma CO., LTD.. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 21
- Miwa Seki 2022-2026 View profile
- Noriaki Nagai 2019-2026 View profile
- Kuniaki Kaga 2018-2025 View profile
- Julia Paige Gregory 2017-2020 View profile
- Tomohiro Tohyama 2011-2025 View profile
- Peter James Jonathan Bains 2010-2018 View profile
- Declan Doogan 2007-2018 View profile
- Eiji Katayama 2007-2008 View profile
- Isao Muramatsu 2007-2011 View profile
- Dr Alan James Lewis 2007-2008 View profile
- Robin Bannister 2007-2008 View profile
- Hiroyuki Hanada 2005-2006 View profile
- Takuya Fujii 2005-2018 View profile
- Sir Mark Henry Richmond 2003-2007 View profile
- David Chiswell 2003-2007 View profile
- Yoshiyuki Yamakawa 2003-2006 View profile
- Yuzo Tarumi 2003-2005 View profile
- Kenzo Nakajima 2002-2006 View profile
- Shinichi Tamura 2002-2025 View profile
- Nobuo Matsuki 2002-2005 View profile
- Edmund Oliver 2002-2005 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- Incorporated
- 01/04/2002
Group
No further corporate or individual controller is recorded above Nxera Pharma CO., LTD. on the PSC register - it appears to be the top of its group.
2 other companies in this group
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
9 directors on the board
- Rolf-Kristian Soderstrom Director · appointed 2020
- Eiko Tomita Director · appointed 2023
- Roblin, David, Doctor Director · appointed 2018
- Christopher Cargill Director · appointed 2022
Directors past 6 years
- Rolf-Kristian Soderstrom Director · appointed 2020
- Roblin, David, Doctor Director · appointed 2018
First-time vs portfolio directors
First-time (3)
- Eiko Tomita Director · appointed 2023
- Roblin, David, Doctor Director · appointed 2018
- Christopher Cargill Director · appointed 2022
Portfolio (1)
- Rolf-Kristian Soderstrom Director · appointed 2020
Left in the last 12 months
- Noriaki Nagai Director · appointed 2019 · resigned 2026
- Miwa Seki Director · appointed 2022 · resigned 2026
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- Several long-serving directors could step down together
- No director brings board experience from anywhere else
- Narrow spread of sectors across the board
Where to look Suggested search: succession planning for long-tenured seats; a director with board experience elsewhere.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- FC024112
- Status
- Active
- Type
- Other company type
- Edition
- Register edition compiled 4th October 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data